Shannon Hansen serves as Executive Vice President, Chief Legal, Privacy and Compliance Officer, and Secretary at Tandem Diabetes Care, Inc., a leading innovator in insulin delivery and diabetes technology. In this multifaceted role, she oversees all legal affairs, privacy initiatives, regulatory compliance, and corporate governance for the company, ensuring alignment with evolving healthcare regulations such as HIPAA, FDA requirements, and data protection laws. Hansen plays a pivotal role in supporting Tandem's growth by mitigating legal risks, facilitating strategic partnerships, and guiding the executive team on ethical decision-making amid the dynamic medtech landscape. With over 20 years of experience in healthcare law and compliance, Hansen began her career at prominent firms like Latham & Watkins, where she specialized in mergers and acquisitions, securities, and regulatory matters. She later held senior legal positions at NuVasive, Inc., advancing to Vice President, Deputy General Counsel, and Chief Compliance Officer, where she spearheaded global compliance programs, managed high-stakes litigation, and navigated complex international regulations during the company's expansion. Her achievements include successfully leading multiple FDA audits, implementing robust privacy frameworks that earned industry accolades, and contributing to billion-dollar acquisitions that strengthened her employers' market positions. Since joining Tandem in 2021, Hansen has been instrumental in enhancing the company's compliance infrastructure to support innovative products like the t:slim X2 insulin pump and t:connect app ecosystem. Under her leadership, Tandem has achieved key milestones, including seamless integrations with continuous glucose monitoring systems and proactive adaptations to post-pandemic privacy standards. Hansen's strategic foresight and collaborative approach continue to empower Tandem's mission of improving diabetes management through cutting-edge, user-centric technology.